These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 37228616)
1. Cellular and transcriptional impacts of Janus kinase and/or IFN-gamma inhibition in a mouse model of primary hemophagocytic lymphohistiocytosis. Albeituni S; Oak N; Tillman HS; Stroh A; Keenan C; Bloom M; Nichols KE Front Immunol; 2023; 14():1137037. PubMed ID: 37228616 [TBL] [Abstract][Full Text] [Related]
2. Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis. Das R; Guan P; Sprague L; Verbist K; Tedrick P; An QA; Cheng C; Kurachi M; Levine R; Wherry EJ; Canna SW; Behrens EM; Nichols KE Blood; 2016 Mar; 127(13):1666-75. PubMed ID: 26825707 [TBL] [Abstract][Full Text] [Related]
3. Differential effects of itacitinib, fedratinib, and ruxolitinib in mouse models of hemophagocytic lymphohistiocytosis. Keenan C; Albeituni S; Oak N; Stroh A; Tillman HS; Wang Y; Freeman BB; Alemán-Arteaga S; Meyer LK; Woods R; Verbist KC; Zhou Y; Cheng C; Nichols KE Blood; 2024 Jun; 143(23):2386-2400. PubMed ID: 38446698 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis. Albeituni S; Verbist KC; Tedrick PE; Tillman H; Picarsic J; Bassett R; Nichols KE Blood; 2019 Jul; 134(2):147-159. PubMed ID: 31015190 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of JAK1/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice. Maschalidi S; Sepulveda FE; Garrigue A; Fischer A; de Saint Basile G Blood; 2016 Jul; 128(1):60-71. PubMed ID: 27222478 [TBL] [Abstract][Full Text] [Related]
10. Combined IFN-γ and JAK inhibition to treat hemophagocytic lymphohistiocytosis in mice. Joly JA; Vallée A; Bourdin B; Bourbonnais S; Patey N; Gaboury L; Théorêt Y; Decaluwe H J Allergy Clin Immunol; 2023 Jan; 151(1):247-259.e7. PubMed ID: 35973477 [TBL] [Abstract][Full Text] [Related]
11. Rapamycin does not control hemophagocytic lymphohistiocytosis in LCMV-infected perforin-deficient mice. Rothman JA; Das R; Teachey DT; Paessler ME; Nichols KE Pediatr Blood Cancer; 2011 Dec; 57(7):1239-43. PubMed ID: 21681935 [TBL] [Abstract][Full Text] [Related]
12. ST2 contributes to T-cell hyperactivation and fatal hemophagocytic lymphohistiocytosis in mice. Rood JE; Rao S; Paessler M; Kreiger PA; Chu N; Stelekati E; Wherry EJ; Behrens EM Blood; 2016 Jan; 127(4):426-35. PubMed ID: 26518437 [TBL] [Abstract][Full Text] [Related]
13. Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis. Keenan C; Nichols KE; Albeituni S Front Immunol; 2021; 12():614704. PubMed ID: 33664745 [TBL] [Abstract][Full Text] [Related]